ArticleThe Lancet regional health. Europe2025

Targeting smouldering neuroinflammation in multiple sclerosis: insights from tolebrutinib clinical trials.

Maria Trojano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.